| Wausau Comprehensive Treatment | |
|
210 Washington St Wausau WI 54403-5543 | |
| (715) 845-3637 | |
| Not Available |
| Full Name | Wausau Comprehensive Treatment |
|---|---|
| Speciality | Community/behavioral Health |
| Location | 210 Washington St, Wausau, Wisconsin |
| Authorized Official Name and Position | Susan Belanger (SUPERVISOR) |
| Authorized Official Contact | 7158453637 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Wausau Comprehensive Treatment 210 Washington St Wausau WI 54403-5543 Ph: (715) 845-3637 | Wausau Comprehensive Treatment 210 Washington St Wausau WI 54403-5543 Ph: (715) 845-3637 |
| NPI Number | 1194256156 |
|---|---|
| Provider Enumeration Date | 03/22/2017 |
| Last Update Date | 03/22/2017 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194256156 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | 18103 (Wisconsin) | Primary |
News Archive
Kolltan Pharmaceuticals, Inc. today announced the presentation of data from a preclinical study evaluating KTN0158 in dogs with spontaneous mast cell tumors. KTN0158 is a proprietary, humanized anti-KIT IgG1 monoclonal antibody drug candidate being developed as a potential therapy for cancer and mast cell-related diseases.
Researchers at Hospital for Special Surgery have identified a potential new target for drugs to treat patients with rheumatoid arthritis (RA), a protein known as IRHOM2. The finding could provide an effective and potentially less toxic alternative therapy to tumor necrosis factor-alpha blockers (TNF-blockers), the mainstay of treatment for rheumatoid arthritis, and could help patients who do not respond to this treatment. Efforts to develop drugs that hone in on this new target are underway.
Mayo Clinic and the Swedish medical university Karolinska Institutet will sign a long-term agreement to collaborate on education, research and innovation. The two institutions, recognized for leadership in medical research, training and patient care, will pursue joint investigations in regenerative medicine, individualized medicine, metabolism, neurosciences and aging research.
Otsuka Canada Pharmaceutical Inc. (OCPI) announced today that Health Canada has issued a notice of compliance for SAMSCA (tolvaptan), the first medicine approved in Canada for the treatment of hyponatremia.
Pancreatic cancer is the fourth leading cause of cancer-related death for both men and women in the United States. As the prevalence of overweight and obesity have rapidly increased during the last 2 decades, accumulating evidence has emerged that excess body weight is a risk factor for pancreatic cancer.
› Verified 9 days ago
Associated Counseling Services, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 614 N 3rd Ave, Suite A, Wausau, WI 54401 Phone: 715-848-3031 Fax: 715-848-5008 | |
The Centre For Well-being, Inc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 901 N 6th St, Wausau, WI 54403 Phone: 715-848-5022 Fax: 888-778-6750 | |
Evans Counseling, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2714 Stewart Ave, Wausau, WI 54401 Phone: 715-849-3988 Fax: 715-849-5838 | |
Tall Pines Behavioral Health Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 100 N 72nd Ave, Wausau, WI 54401 Phone: 715-301-0267 | |
Transformation Counseling And Training Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1720 Merrill Ave Ste 305, Wausau, WI 54401 Phone: 715-903-6519 | |
New Insights Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 516 Mcclellan St, Wausau, WI 54403 Phone: 715-226-6441 |